Research Topics
| Sonia FriedmanSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel diseaseS Friedman
Division of Gastroenterology, Mount Sinai Medical Center, New York, New York, USA
Inflamm Bowel Dis 7:1-7. 2001..Pyoderma gangrenosum complicates inflammatory bowel disease in 2-3% of patients and often fails to respond to antibiotics, steroids, surgical debridement or even colectomy...- Management of inflammatory bowel disease during pregnancy and nursingS Friedman
Gastroenterology Division, Harvard Medical School, Brigham and Women s Hopital, Boston, MA 02115, USA
Semin Gastrointest Dis 12:245-52. 2001..Pregnant IBD patients should be followed in a facility where diagnostic tests, such as sigmoidoscopy and ultrasound, and surgery can be performed if necessary... - Management of neoplastic polyps in inflammatory bowel diseaseSonia Friedman
Gastroenterology Division, Harvard Medical School, Brigham and Women s Hospital, ASBII, Boston, Massachusetts, U S A
Inflamm Bowel Dis 9:260-6. 2003..As long as there is no flat dysplasia or adenocarcinoma elsewhere in the colon, a colectomy is not required. However, this group of patients requires increased colonoscopic surveillance... - Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 yearsSonia Friedman
Division of Gastroenterology, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Clin Gastroenterol Hepatol 6:993-8; quiz 953-4. 2008..Our initial results through August 1998 showed a 22% chance of developing definite dysplasia or cancer by the fourth surveillance examination. We now update the results of all examinations since September 1998 until April 2005... - General principles of medical therapy of inflammatory bowel diseaseSonia Friedman
Gastroenterology Division ASBII, Department of Medicine, Harvard Medical School, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Gastroenterol Clin North Am 33:191-208, viii. 2004..Finally, it provides a summary of the current accepted medical therapies for ulcerative colitis adn Crohn's disease and recommendations for using these medications in clinical practice... - Cancer in Crohn's diseaseSonia Friedman
Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
Gastroenterol Clin North Am 35:621-39. 2006..The study of cancers that are associated with CD is an evolving field that surely will change given that immunomodulators and biologics are being used with greater frequency... - Differential regulation of peripheral leukocyte genes in patients with active Crohn's disease and Crohn's disease in remissionRobert Burakoff
Brigham and Women s Hospital, GI Division, Boston, MA 02115, USA
J Clin Gastroenterol 44:120-6. 2010..Specific gene expression patterns and molecular biomarkers associated with active Crohn's disease could serve as such markers, thereby providing a novel approach to disease activity monitoring... - 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprineScott Hande
Brigham and Women s Hospital, Boston, Massachusetts, USA
Inflamm Bowel Dis 12:251-7. 2006..We tested the theory that coadministration of 5-ASA agents with AZA/6-MP results in higher 6-TGn levels in a large cohort of children and adults with CD or ulcerative colitis (UC)... - Are patients with inflammatory bowel disease receiving optimal care?Sarathchandra I Reddy
Division of Gastroenterology, Crohn's and Colitis Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Am J Gastroenterol 100:1357-61. 2005.... - Blood-based biomarkers can differentiate ulcerative colitis from crohn's disease and noninflammatory diarrheaRobert Burakoff
Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
Inflamm Bowel Dis 17:1719-25. 2011..A blood test with the ability to differentiate Crohn's disease (CD) from ulcerative colitis (UC) and noninflammatory diarrhea would be useful in the clinical management of these diseases... - Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn diseasePaul B Shyn
Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Nucl Med 51:1841-8. 2010..The purpose of this study was to evaluate the diagnostic efficacy of low-dose, combined (18)F-FDG PET/CT enterography (PET/CTE), compared with CT enterography (CTE) alone, in the assessment of patients with Crohn disease... - Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findingsJonathan N Glickman
Department of Pathology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Am J Surg Pathol 28:190-7. 2004..Therefore, the objectives of this study were to determine the clinical and pathologic features of new-onset UC in children and to compare the initial presentation of UC in this group with a control group of adults... - Pregnancy and nursing in inflammatory bowel diseaseSonia Friedman
Department of Medicine, Harvard Medical School, and Gastroenterology Division, Brigham and Women's Hospital, Boston, MA, USA
Gastroenterol Clin North Am 31:265-73, xii. 2002..This article outlines fertility in IBD, the effect of IBD on pregnancy, the effect of pregnancy on IBD, and the medical therapy available... - MDCT assessment of ulcerative colitis: radiologic analysis with clinical, endoscopic, and pathologic correlationBijal Patel
Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Abdom Imaging 37:61-9. 2012..Evaluate the utility of multidetector-row computed tomography (MDCT) in assessing the severity of ulcerative colitis (UC) in comparison with clinical assessment, colonoscopy, and histopathology... - Granulomatous tracheo-bronchitis associated with Crohn's diseaseKai Xia
Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA
MedGenMed 6:18. 2004..The patient improved with a 6-week oral, followed by an additional 4-week inhaled, corticosteroid treatment. Since then, he has been doing well without relapse of pulmonary symptoms for 2 years... - Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurineMiles P Sparrow
Section of Gastroenterology and Nutrition, University of Chicago Medical Center, Chicago, Illinois, USA
Clin Gastroenterol Hepatol 5:209-14. 2007..We describe the use of allopurinol in AZA/6-MP nonresponders to deliberately shunt metabolism of 6-MP toward 6-thioguanine (6-TGN) and improve clinical responses... - Medical therapy and birth outcomes in women with Crohn's disease: what should we tell our patients?Sonia Friedman
Am J Gastroenterol 102:1414-6. 2007..Only a prospective pregnancy registry of IBD patients can adequately differentiate the effects of disease activity and medication use on adverse pregnancy outcomes...